The effect of cefodizime on phagocyte function in non-patient volunteers and patients with chronic renal failure: In vitro and ex vivo studies

International Journal of Clinical and Laboratory Research

Volumn 26, Issue 4, 1996, Pages 229-235

  McCafferty, A C ^a   McGregor, E ^b   Jones, M ^b   Henderson, I S ^b   Cree, I A ^c  

^a Knight Scientific Ltd   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cefodizime; Chemiluminescence; Chronic renal failure; Phagocytes; Polarization

Indexed keywords

EID: 0030454924     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02602954     Document Type: Article

References (31)

1. Lewis SL, Van Epps DE. Neutrophil and monocyte alterations in chronic dialysis patients. Am J Kidney Dis 1987; 5:381.
2. Harvey DM, Sheppard KJ, Morgan AG, Fletcher J. Neutrophil function in patients on continuous ambulatory peritoneal dialysis. Br J Haematol 1988; 68:271.
3. Labro MT. Cefodizime as a biological response modifier: a review of its in vivo, ex-vivo, and in-vitro immunomodulatory properties. J Antimicrob Chemother 1990; 26 [Suppl] C:37.
4. Vanholder R, Dagrosa EE, Van Landschoot N, Waterloos MA, Ringoir SMG. Antibiotics and energy delivery to the phagocytosis-associated respiratory burst in chronic hemadialysis patients: a comparison of cefodizime and cotrimoxazole. Nephron 1993; 63:65.
5. Vanholder R, Van Landschoot N, Dagrossa E, Ringoir S. Cefodizime: a new cephalosporin with apparent immune-stimulating properties in chronic renal failure. Nephrol Dial Transplant 1988; 2:221.
6. McCafferty AC, Cree IA, McMurdo MET. The influence of age and sex on phagocyte chemiluminescence. J Biolumin Chemilum 1995; 10:41.
7. Wilkinson PC. Locomotion and chemotaxis of leukocytes. In: Weir DM, ed. Handbook of experimental immunology, 4th edn, vol 2. Oxford: Blackwell; 1986: chapter 51.
8. Haslett C, Guthrie LA, Kopaniak MM, Johnston RB Jr, Henson PM. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 1985; 119:101.
9. Blair AL, Cree IA, Beck JS, Hastings MJG. Measurement of phagocyte chemiluminescence in a microtitre plate format. J Immunol Methods 1988; 112:163.
10. Blair AL, Cree IA, Beck JS. Measurement of phagocyte chemiluminescence using a microtitre plate luminometer. J Biolumin Chemilum 1989; 3:67.
11. Blair AL, Cree IA, Beck JS. Phagocytosis of mycobacteria by heat-stable opsonins in tuberculosis and leprosy. FEMS Microbiol Immunol 1993; 7:197.
12. Cree IA, Blair AL, Beck JS. Use of a microtitre plate chemiluminescence reader to study surface phagocytosis by human monocytes. J Biolumin Chemilum 1989; 3:71.
13. Cree IA. Longitudinal studies of phagocyte chemiluminescence in patients with lung disease. In: Szalay A, Kricka LJ, Stanley PE, eds. Chemiluminescence and bioluminescence. Status report. Chichester: Wiley; 1993:451-455.
14. Mulvaney J, Bilsland D, Cree IA, Ferguson J. Neutrophil chemiluminescence (CL) in psoriasis using a microtitre plate luminometer. In: Stanley PE, Kricka LJ, eds. Bioluminescence and chemiluminescence. Current status. Chichester: Wiley; 1991: 313-316.
15. Moussa K, Michie HJ, Cree IA, MacCafferty A, Winter JH, Brown RA. Phagocyte function and cytokine production in community-acquired pneumonia. Thorax 1994; 49: 107.
16. Pierce LA, Cree IA, Blair AL, Tarnow-Mordi WO. The effect of ammoglycosides on human polymorpho-nuclear leukocyte (PMNL) chemiluminescence. In: Stanley PE, Kricka LJ, eds. Bioluminescence and chemiluminescence. Current status. Chichester: Wiley; 1991:317.
17. Pierce LA, Cree IA, Tarnow-Mordi WO. Antibiotic effects on phagocyte chemiluminescence in vitro. Int J Lab Clin Sci 1995; 25:93.
18. Ramage L, Blair AL, Cree IA, Dhillon DP. Effect of salmeterol on polymorphonuclear leukocyte (PMNL) function in vitro. J Biolumin Chemilum 1993; 8:247.
19. Ramage L, Cree IA, Blair AL, Dhillon DP. The effect of beta-agonists on polymorphonuclear cell (PMNL) function in vitro. In: Stanley PE, Kricka LJ, eds. Bioluminescence and chemiluminescence. Current status. Chichester: Wiley; 1991:309-312.
20. McCafferty AC, Cree IA. Measurement of cell migration stimulated by interleukin 8: use of ATP chemiluminescence. Cytokine 1994; 6:450.
21. Hunter EM, Sutherland LA, Cree IA, Dewar JA, Preece PE, Andreotti PE. Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assay. Eur J Surg Oncol 1993; 19:242.
22. Limbert M, Bartlett R, Dickneite G, Kiesel N, Schorlemmer HU, Seibert G, et al. Cefodizime, an aminothiazolyl cephalosporin. IV. Influence on the immune system. J Antibiot (Tokyo) 1984; 37:1719.
23. Kiesel N, Limbert M, Seibert G, Winkler I, Schrinner E. Cefodizime, an aminothiazolyl cephalosporin. III. Therapeutic activity against experimentally induced pneumonia in mice. J Antibiot (Tokyo) 1984; 38:1712.
24. Nomura S, Nagayama A. Mechanism of enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime. Chemotherapy 1995; 41:267.
25. Nomura S, Nagayama A. In vitro and in vivo enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime. Chemotherapy 1995; 41:178.
26. Labro MT, Babin-Chevaye C, Hakim J. Effects of cefotaxime and cefodizime on human granulocyte functions in vitro. J Antimicrob Chemother 1986; 18:233.
27. Wenisch C, Parschalk B, Hasenhundl M, Wiesinger E, Graninger W. Effect of cefodizime and ceftriaxone on phagocytic function in patients with severe infections. Antimicrob Agents Chemother 1995; 39:672.
28. Partsch G, Schwarzer C. An indirect bioluminescence method for quantitative measurement of polymorphonuclear cell chemotaxis. J Biolumin Chemilum 1991; 6:159.
29. Shaio MF, Chang FY. Influence of cefodizime on chemotaxis and the respiratory burst in neutrophils from diabetics. J Antimicrob Chemother 1990; 26:55.
30. Labro MT, Amit N, Babin-Chevaye C, Hakim J. Cefodizime (HR221) potentiation of human neutrophil oxygen-independent bactericidal activity. J Antimicrob Chemother 1987; 19:331-341.
31. Meloni F, Ballabio P, Bianchi L, Grassi FA, Gialdroni-Grassi GG. Cefodizime modulates in vitro tumor necrosis factor-alpha, interleukin-6 and interleukin-8 release from human peripheral monocytes. Chemotherapy 1995; 41:289.